Insider Trading & Ownership of ELI LILLY & Co

Location
Indianapolis, IN
Summary
The estimated value of insider holdings of ELI LILLY & Co is at least $1,492 dollars as of 14 Aug 2023. ELI LILLY & Co is the 10%+ Owner of Sigilon Therapeutics, Inc. and owns shares of Sigilon Therapeutics, Inc. stock worth about $1.5K.
Signature
/s/ Anat Ashkenazi, Executive Vice President and Chief Financial Officer, on behalf of Eli Lilly and Company
All Insider Reports
All Insider Reports

Notify me when ELI LILLY & Co files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of ELI LILLY & Co

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SGTX Sigilon Therapeutics, Inc. 10%+ Owner $1,492 11 Aug 2023

Insider Transactions Reported by ELI LILLY & Co:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.